BNP PARIBAS FINANCIAL MARKETS - GLOBUS MED INC ownership

GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 343 filers reported holding GLOBUS MED INC in Q3 2020. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of GLOBUS MED INC
ValueSharesWeighting
Q3 2023$1,764,015
-81.0%
35,529
-77.2%
0.00%
-83.3%
Q2 2023$9,290,324
+6.3%
156,035
+1.1%
0.01%0.0%
Q1 2023$8,740,062
+347.3%
154,309
+486.6%
0.01%
+300.0%
Q4 2022$1,953,821
-99.9%
26,307
-40.1%
0.00%
-25.0%
Q3 2022$2,614,766,000
+50.2%
43,894
+41.5%
0.00%
+33.3%
Q2 2022$1,740,958,000
-54.5%
31,011
-40.2%
0.00%
-40.0%
Q1 2022$3,826,747,000
+245.2%
51,867
+237.8%
0.01%
+150.0%
Q4 2021$1,108,559,000
-8.8%
15,354
-3.2%
0.00%0.0%
Q3 2021$1,215,806,000
-9.8%
15,868
-8.7%
0.00%0.0%
Q2 2021$1,348,169,000
+36.2%
17,389
+8.3%
0.00%
+100.0%
Q1 2021$989,865,000
+125.1%
16,051
+138.0%
0.00%0.0%
Q4 2020$439,778,000
+23.3%
6,743
-6.4%
0.00%0.0%
Q3 2020$356,792,000
-60.8%
7,205
-62.3%
0.00%
-50.0%
Q2 2020$910,879,000
-71.3%
19,092
-74.4%
0.00%
-71.4%
Q1 2020$3,174,184,000
+250.7%
74,634
+385.6%
0.01%
+250.0%
Q4 2019$904,986,000
+17.8%
15,370
+2.3%
0.00%
+100.0%
Q3 2019$768,282,000
+107.1%
15,029
+71.4%
0.00%0.0%
Q2 2019$370,886,000
-53.4%
8,768
-45.6%
0.00%
-50.0%
Q1 2019$796,637,000
+982.7%
16,123
+848.4%
0.00%
Q4 2018$73,576,000
-84.4%
1,700
-79.6%
0.00%
-100.0%
Q3 2018$472,300,000
-7.4%
8,321
-17.7%
0.00%0.0%
Q2 2018$510,302,000
-50.5%
10,113
-51.1%
0.00%
-50.0%
Q1 2018$1,030,278,000
-23.5%
20,680
-36.9%
0.00%0.0%
Q4 2017$1,347,135,000
+32.7%
32,777
-4.1%
0.00%0.0%
Q3 2017$1,015,532,000
-22.1%
34,170
-13.2%
0.00%
-50.0%
Q2 2017$1,304,386,000
+128.5%
39,348
+104.2%
0.00%
+100.0%
Q1 2017$570,837,000
-16.3%
19,272
-29.9%
0.00%
-33.3%
Q4 2016$681,779,000
+256.5%
27,480
+224.3%
0.00%
+200.0%
Q3 2016$191,236,000
+65.4%
8,473
+74.6%
0.00%0.0%
Q2 2016$115,623,000
+85.7%
4,852
+85.1%
0.00%
Q1 2016$62,249,000
-85.8%
2,621
-83.4%
0.00%
-100.0%
Q4 2015$439,278,000
+48.2%
15,790
+10.1%
0.00%0.0%
Q3 2015$296,409,000
+13.2%
14,347
+40.7%
0.00%0.0%
Q2 2015$261,783,000
+86.4%
10,198
+83.3%
0.00%
Q1 2015$140,435,000
+47.7%
5,564
+39.1%
0.00%
Q4 2014$95,080,000
+24.9%
4,000
+3.3%
0.00%
Q3 2014$76,143,000
+2488.1%
3,871
+3047.2%
0.00%
Q2 2014$2,942,000
-79.4%
123
-82.7%
0.00%
Q4 2013$14,308,000
-94.6%
709
-95.3%
0.00%
Q3 2013$262,808,000
-26.3%
15,052
-28.9%
0.00%
Q2 2013$356,774,00021,1610.00%
Other shareholders
GLOBUS MED INC shareholders Q3 2020
NameSharesValueWeighting ↓
Consonance Capital Management LP 908,953$59,282,0005.54%
Sterling Investment Advisors, Ltd. 234,623$15,302,0005.20%
Next Capital Management LLC 111,098$7,246,0005.10%
Godshalk Welsh Capital Management, Inc. 77,085$5,027,0003.71%
Pembroke Management, LTD 613,931$40,041,0003.36%
XXEC, Inc. 52,800$3,444,0002.71%
Global Alpha Capital Management Ltd. 302,377$19,721,0002.42%
Van Berkom & Associates Inc. 1,572,303$102,546,0002.35%
PARADIGM CAPITAL MANAGEMENT INC/NY 581,700$37,939,0002.27%
RTW INVESTMENTS, LP 1,640,859$107,017,0001.80%
View complete list of GLOBUS MED INC shareholders